Who Should Avoid GLP-1s
He has also received grants from Medical Research Council, European Union, JPND, Alzheimers Research, UK, Alzheimers Drug Discovery Foundation, Alzheimers Society, UK, Alzheimers Association, US, Medical P.E
Retatrutide has shown the highest weight loss numbers in trials so far (28.7% in Phase 3 TRIUMPH-4 vs 22.5% for tirzepatide in SURMOUNT-1 and 15.8% for semaglutide in STEP-1)
You also shouldn't take it if you have glaucoma, hyperthyroidism, or a history of drug abuse, or if you are pregnant or nursing
The disconnect stems from how GLP-1 medications are traditionally prescribed and supported
Inflammatory subgroups of schizophrenia and their association with brain structure: a semi-supervised machine learning examination of heterogeneity